Prevention of the liquoid-induced consumption coagulopathy by the protease inhibitor aprotinin.
D000818:Animals; D007611:Aprotinin / Q000494:pharmacology / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced / Q000517:prevention & control*; D005174:Factor XII / Q000037:antagonists & inhibitors*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006400:Hematocrit; D006470:Hemorrhage / Q000188:drug therapy; D008168:Lung; D008297:Male; D011817:Rabbits; D012790:Shwartzman Phenomenon / Q000517:prevention & control*; D013451:Sulfonic Acids; D013501:Surface-Active Agents
D013451:Sulfonic Acids; D013501:Surface-Active Agents; D005174:Factor XII; D005340:Fibrinogen; D007611:Aprotinin